Global Blood Therapeutics OverviewGlobal Blood Therapeutics Net Income
Profitability analysis for GBT.
Quarterly Net Income
-$82.47M
↓ 18.51% YoY
As of Jun 2022
Annual Net Income (TTM)
-$326.38M
↓ 22.6% YoY
Trailing 12 months ending Jun 2022
Average Net Income (Comparison Companies)
Net Income History
Net Income Comparison
Annual Net Income Growth Rate (%)
Loading...
Annual Net Income Growth (Absolute)
Loading...